Alkeon Capital Management LLC Karyopharm Therapeutics Inc. Transaction History

Alkeon Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$5.91 - $14.38 $11.6 Million - $28.2 Million	-1,961,588 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$4.45 - $10.63 $3.12 Million - $7.46 Million	-701,589 Reduced 26.34%	1,961,588 $11.4 Million
Q2 2021 Aug 16, 2021	SELL	$8.11 - $11.11 $40,728 - $55,794	-5,022 Reduced 0.19%	2,663,177 $27.5 Million
Q1 2021 May 17, 2021	BUY	$9.85 - $17.69 $17,562 - $31,541	1,783 Added 0.07%	2,668,199 $28.1 Million
Q4 2020 Feb 16, 2021	BUY	$14.15 - $17.19 $7.1 Million - $8.62 Million	501,516 Added 23.17%	2,666,416 $41.3 Million

Q3 2020 Nov 16, 2020	BUY	$14.14 - $19.71 $1.41 Million - $1.97 Million	100,000 Added 4.84%	2,164,900 $31.6 Million
Q2 2020 Aug 14, 2020	SELL	$16.6 - $25.25 $1.66 Million - $2.53 Million	-100,000 Reduced 4.62%	2,064,900 $39.1 Million
Q1 2020 May 15, 2020	BUY	$14.38 - $27.72 $29.3 Million - $56.5 Million	2,039,900 Added 1631.92%	2,164,900 $41.6 Million
Q4 2019 Feb 14, 2020	BUY	$9.23 - $19.67 $1.15 Million - $2.46 Million	125,000 New	125,000 $2.4 Million

120

72.4M

476K

175K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $69.4M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Alkeon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alkeon Capital Management LLC with notifications on news.